Axxcess Wealth Management LLC Has $2.66 Million Stock Position in Astera Labs, Inc. $ALAB

Axxcess Wealth Management LLC lifted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 219.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,590 shares of the company’s stock after buying an additional 9,342 shares during the period. Axxcess Wealth Management LLC’s holdings in Astera Labs were worth $2,661,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ALAB. Vanguard Group Inc. grew its position in Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after acquiring an additional 1,693,918 shares during the last quarter. State Street Corp boosted its stake in shares of Astera Labs by 39.3% during the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after purchasing an additional 604,363 shares in the last quarter. 1832 Asset Management L.P. grew its holdings in shares of Astera Labs by 151.4% during the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock worth $139,563,000 after purchasing an additional 929,600 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in shares of Astera Labs by 46.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock valued at $295,203,000 after buying an additional 479,360 shares during the period. Finally, Geode Capital Management LLC raised its holdings in Astera Labs by 36.2% in the 2nd quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock valued at $112,562,000 after buying an additional 330,841 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. JPMorgan Chase & Co. boosted their target price on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Barclays set a $165.00 target price on Astera Labs in a report on Thursday, January 15th. Raymond James Financial started coverage on Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating for the company. Finally, Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Fourteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $192.89.

Insider Buying and Selling

In other news, CEO Jitendra Mohan sold 94,971 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the transaction, the chief executive officer directly owned 1,452,739 shares in the company, valued at $179,863,615.59. This trade represents a 6.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Manuel Alba sold 150,000 shares of the business’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the sale, the director directly owned 1,574,498 shares of the company’s stock, valued at approximately $261,650,077.64. The trade was a 8.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 389,792 shares of company stock worth $56,013,809 over the last quarter. Corporate insiders own 12.50% of the company’s stock.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Seeking Alpha highlights that revenue more than doubled year‑over‑year and free cash flow margins remain strong (above 30%), with a cash balance ~ $1.19B and no debt — supporting financial flexibility and giving investors confidence in the business. The Great Astera Labs Reset
• Positive Sentiment: Analyst commentary (Zacks) points to surging AI connectivity demand and Astera’s expansion of NVLink/Scorpio product lines, which could drive a much larger TAM (analysts mention a potential 10x market to ~$25B over five years) — a growth narrative that tends to support higher multiples. ALAB Rides on Strong Connectivity Demand
• Neutral Sentiment: Reported short interest data is essentially zero / unchanged (short‑interest ratio ~0 days) — little visible short pressure to amplify moves in either direction at present.
• Negative Sentiment: CEO Jitendra Mohan sold 94,971 shares at ~$123.81 (reported Feb 17), a ~6.14% reduction in his holdings — a sizable insider sale that can weigh on sentiment. CEO Form 4
• Negative Sentiment: COO Sanjay Gajendra sold 94,971 shares at ~$123.81 (reported Feb 17), a ~5.84% cut to his stake — adds to the cluster of large insider sales. COO Form 4
• Negative Sentiment: CFO Michael Truett Tate sold 12,001 shares at ~$123.81 (reported Feb 17), a ~5.88% reduction in his holdings — another insider liquidity event to note. CFO Form 4
• Negative Sentiment: General Counsel Philip Mazzara sold 4,849 shares at ~$123.80 (reported Feb 17), a ~3.39% cut to his stake — part of the same round of insider sales. GC Form 4

Astera Labs Trading Up 2.3%

Shares of NASDAQ ALAB opened at $132.62 on Friday. The firm has a market capitalization of $22.40 billion, a P/E ratio of 108.70, a P/E/G ratio of 2.55 and a beta of 1.50. The firm’s 50-day moving average price is $160.78 and its 200-day moving average price is $174.12. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The firm’s revenue was up 91.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.